In a previous article, we discussed the role of the AIFM of a Luxembourg alternative investment fund (AIF) in a fund financing transaction.

The Luxembourg law of March 3, 2026 transposed the AIFMD II Directive into national law, introducing significant changes to the regulatory framework governing alternative investment funds. This article examines the practical implications for financing transactions involving Luxembourg AIFs, analyzing how the new rules on loan origination, leverage caps, concentration limits, and enhanced disclosure requirements affect both lenders and borrowers in structured finance arrangements.

Regulated funds, SIFs and RAIFs should automatically qualify for the CIV Exemption.

In the private credit space, side letters remain crucial for tailoring fund terms to the regulatory, tax, operational and policy needs of investors. They are a key feature of private credit fund negotiations...

The bill would have prohibited sales of most of the covered products starting in 2028, and of nonstick cookware containing polytetrafluoroethylene ("PTFE") and other PFAS beginning in 2030.

The Securities and Exchange Commission (SEC) has issued a concept release seeking public comment on the definition of "foreign private issuer" (FPI), marking its first comprehensive review of the regulatory framework since 2007.

The United Kingdom's unprecedented vote to leave the European Union (Brexit) has dramatically upended global markets.

At the 2025 Private Credit Summit, hosted in New York by Dechert, ING and KBW/Stifel, Dechert partner and permanent capital practice co-head Bill Bielefeld moderated an esteemed panel...

Last week, the SEC withdrew 14 proposed regulatory actions that had been pending for several years, including a number of proposed rules that would have had a major impact on investment advisers and funds.

The U.S. Department of Health and Human Services is conducting office closures, workforce reductions and other organizational changes that will affect its operations.

The Gardasil MDL opinion reinforces that preemption remains a powerful defense when plaintiffs cannot identify both the existence and timing of...

The Supreme Court of Maryland's rulings provide additional powerful precedent rejecting efforts to target complex societal issues through public nuisance actions against lawful, regulated industries.

The global national security and foreign direct investment ("FDI") review landscape continues to evolve.

Zurbriggen underscores that plaintiffs alleging injury from consumer products must present reliable expert causation evidence and signals courts’ resistance to the use of equitable doctrines like res ipsa loquitur to substitute for proof of defect, exposure, and causation.

This ruling may open the door to broader discovery of expert AI usage. Parties should consider addressing AI usage explicitly in their discovery protocols and agreements rather than relying on general provisions that courts may decline to extend to novel AI-assisted workflows.

AI-enabled cyber threats increased exponentially in 2025; vishing and deep fakes abounded. Companies fought to keep up by adopting AI tools to thwart these attacks.

The Fifth Circuit denied the FTC's request for a stay pending appeal, leaving in place the district court's decision finding the new HSR Rules unlawful...

The SEC has issued a series of no-action letters and proposed rules that are reshaping the regulatory framework for business development companies and closed-end funds. From co-investment relief extensions to potential blue sky preemption, these developments signal a notable shift in the agency's approach to fund regulation and capital formation.

Dechert Re:Torts delivers monthly insights and analysis on significant legal trends, landmark cases, and strategic considerations for businesses navigating complex product liability and mass torts litigation. Stay informed about the evolving landscape of tort law and its implications across various industries.

This monthly newsletter examines significant legal trends and landmark cases in product liability and mass torts, from RICO liability in fabricated medical records schemes to AI chatbot regulation and PFAS drinking water standards. The analysis covers critical developments including the Supreme Court's FIFRA preemption ruling in Roundup litigation, bankruptcy estate successor liability clarifications, and emerging issues around AI-generated expert testimony.